Drug Type Mesenchymal stem cell therapy |
Synonyms bone marrow-derived mesenchymal stromal cells(The University of Queensland), Bone-marrow derived MSCs(The University of Queensland) |
Target- |
Action- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Allograft Rejection | Phase 2 | Australia | 21 Apr 2017 | |
| Coronary Artery Disease | Phase 2 | Spain | 31 Mar 2013 | |
| Idiopathic cardiomyopathy | Phase 2 | Spain | 31 Mar 2013 | |
| Cardiomyopathy, Dilated | Phase 2 | Spain | 01 Mar 2013 | |
| Liver Cirrhosis, Alcoholic | Phase 1 | United States | 20 Jun 2019 |
Phase 3 | 475 | (Bone Marrow Derived MSCs) | blsacejmho(qgngpzpwnf) = yqrzvsquei ckmqwuxuhy (onlnqnsyuj, 2.52) View more | - | 27 Jul 2023 | ||
Adipose-derived MSCs (Adipose-derived MSCs) | blsacejmho(qgngpzpwnf) = gyiyauiylv ckmqwuxuhy (onlnqnsyuj, 2.48) View more | ||||||
HOVON-113 (EHA2022) Manual | Phase 3 | 41 | Mesenchymal stromal cell | drcejoqxey(qmgtziyemu) = zbkaqtrsot qztnzbcsyp (krxhovbdmo ) View more | Negative | 12 May 2022 | |
placebo | drcejoqxey(qmgtziyemu) = jzeiswcnuh qztnzbcsyp (krxhovbdmo ) View more |





